ALLTERUM THERAPEUTICS
Allterum Therapeutics is a biopharmaceutical company that develops treatments for relapsed acute lymphoblastic leukemia and other IL-7R expressing cancers. The company is also exploring relapsed/refractory solid tumors with IL-7R over-expression. The 4A10 antibody was developed at the National Cancer Institutes (NCI) and licensed exclusively to Fannin Innovation Studio.
ALLTERUM THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2018-01-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.allterum.com
Total Employee:
1+
Status:
Active
Total Funding:
16.7 M USD
Technology used in webpage:
U.S. Server Location Akismet Akismet Non Hosted Accelerated Mobile Pages
Similar Organizations
Century Therapeutics
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Harmony Biosciences
Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Current Employees Featured
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Allterum Therapeutics
Fannin Innovation Studio
Fannin Innovation Studio investment in Seed Round - Allterum Therapeutics
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Allterum Therapeutics
Official Site Inspections
http://www.allterum.com
- Host name: 192.0.78.151
- IP address: 192.0.78.151
- Location: San Francisco United States
- Latitude: 37.7506
- Longitude: -122.4121
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94110
More informations about "Allterum Therapeutics"
Allterum Therapeutics
Allterum Therapeutics is building an oncology franchise targeting the IL-7 axis starting with a monoclonal antibody against CD127 (also known as IL-7Rα). Developing treatments for …See details»
About Us | Allterum Therapeutics
With an initial focus on hematological malignancies, Allterum Therapeutics is developing 4A10, an anti-CD127 monoclonal antibody for treating acute …See details»
Allterum Therapeutics - Crunchbase Company Profile …
Allterum Therapeutics may be growing due to a significant grant acquisition to support clinical evaluation of a cancer-fighting drug. The company has …See details»
ABOUT ALLTERUM | Allterum Therapeutics
ABOUT ALLTERUM . Developing treatments for CD127 expressing cancers. Contact Us. Email [email protected]. Location 3900 Essex Lane. Ste 575, Houston, Texas 77027 …See details»
Allterum Therapeutics - Funding, Financials, Valuation & Investors
Allterum Therapeutics is a biopharmaceutical company that develops treatments for different types of cancers. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much …See details»
Allterum Therapeutics - LinkedIn
Allterum Therapeutics | 373 followers on LinkedIn. Developing Treatments for ALL. | Allterum Therapeutics is a biopharmaceutical company developing an immunotherapy for pediatric acute ...See details»
Allterum Therapeutics - Contacts, Employees, Board Members
Organization. Allterum Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. About. …See details»
Allterum Therapeutics Overview | SignalHire Company Profile
Allterum Therapeutics is a biopharmaceutical company developing an immunotherapy for pediatric acute lymphoblastic leukemia. ... Organization Website: allterum.com : Social Links: …See details»
Allterum - 2025 Company Profile, Funding & Competitors - Tracxn
Mar 12, 2025 Allterum. has raised a total funding of $65.8M over 4 rounds. What are the most recent funding rounds of Allterum? Its latest funding round was a Series A round on Jan 20, …See details»
TEAM | Allterum Therapeutics
Eric Schafer M.D., M.H.S. Assist. Professor Pediatrics-Oncology Baylor College of Medicine & Texas Children’s HospitalSee details»
GBI Biomanufacturing and Allterum Therapeutics Announce …
Oct 7, 2024 GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), and Allterum Therapeutics, a Fannin-Founded Company, are pleased …See details»
Houston biotech startup raises millions to battle pediatric cancer
Jan 21, 2021 Allterum's antibody therapy is designed to effectively treat those patients. Later this year, Allterum plans to seek FDA approval to proceed with concurrent first- and second-phase …See details»
A New Era for Allterum Therapeutics: Dr. Yan Moore Takes the …
Jan 6, 2025 Allterum’s roots in Houston—a city known for its groundbreaking medical advancements and home to the world-renowned Texas Medical Center—further amplify the …See details»
Allterum | VentureRadar
With an initial focus on hematological malignancies, Allterum Therapeutics is developing 4A10, an anti-CD127 monoclonal antibody for treating acute lymphoblastic leukemia (ALL), B-cell …See details»
GBI Biomanufacturing and Allterum Therapeutics Announce …
Oct 7, 2024 PLANTATION, Florida and HOUSTON, Texas, Oct. 7, 2024 /PRNewswire/ — GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), …See details»
OUR PARTNERS & COLLABORATORS - Allterum
Sarah’s lab is collaborating with Allterum to evaluate 4A10 in PDX models of B-ALL. ... Los Angeles, CA Allterum will work with TACL to design, run, and manage its Phase I clinical trial. …See details»
Allterum partners with GBI to manufacture mAb for clinical trial
Oct 9, 2024 The Florida-based contract development and manufacturing organization (CDMO) will produce an antibody for acute lymphoblastic leukemia (ALL). Josh Abbott, Editor ...See details»
GBI Biomanufacturing and Allterum Therapeutics Announce …
Oct 7, 2024 PLANTATION, Florida and HOUSTON, Texas, Oct. 7, 2024 /PRNewswire/ -- GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), …See details»
OUR SCIENCE & RESEARCH - Allterum
Allterum is building a franchise addressing the CD127 pathway starting with 4A10, a monoclonal antibody targeted against CD127. CD127 is part of a receptor complex located on T-cells and …See details»
Allterum Therapeutics closes $2.9 million CPRIT award to develop …
HOUSTON, April 21, 2020 /PRNewswire/ -- Allterum Therapeutics, Inc., a Fannin Innovation Studio company, has closed on a $2.9 million Product Development award by the Cancer …See details»